Following previous ticker characteristics, Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) also run on active notice, stock price jumped up 14.21% after traded at $4.26 in most recent trading session.
Biostar Pharmaceuticals, Inc. (BSPM) reported that it completed the sale of 425,000 shares of ordinary stock at the price of $4.50 per share, and warrants to purchase 212,500 shares of ordinary stock to institutional investors for gross proceeds of about $1.91 million. The warrants will be exercisable six months and one day from the date of the closing of the offering at an exercise price of $5.55 per share and expire 3 1/2 years from the date of issuance.
Moving toward ratio analysis, it has current ratio of 1.30 and quick ratio was calculated as 1.30. The debt to equity ratio appeared as 0.07 for seeing its liquidity position. Taking notice on volatility measures, price volatility of stock was 20.34% for a week and 21.19% for a month. The price volatility’s Average True Range for 14 days was 0.77. On these bases, analysts would recommend this stock as an “Active Revolving Stocks.” The firm attains analyst recommendation of 1.00 out of 1-5 scale with week’s performance of -23.24%. BSPM’s institutional ownership was registered as 7.10%, while insider ownership was 32.50%.
SCYNEXIS, Inc. (NASDAQ:SCYX) persists its position slightly strong in context of buying side, while shares price moved down -0.51% during latest trading session.
Narrow down focus to other ratios, the co has current ratio of 11.70 that indicates if SCYX lies in 1.3% to 3% then it is acceptable for both active and passive investors, but sometimes its varies industry to industry. Generally, it indicates good short-term financial strength. Street is more conscious on this after SunEdison, Inc. case. To make strengthen these views, the active industry firm has Quick Ratio of 11.70, which indicates firm has sufficient short-term assets to cover its immediate liabilities. In addition, the firm has debt to equity ratio of 0.00, sometimes its remain same with long term debt to equity ratio.